Microsoft Corp MSFT:NASDAQ

Last Price$203.19NASDAQ Closing Price as of 4:00PM ET 9/24/20
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change+2.60(1.30%)
Bid (Size)$203.51 (1)
Ask (Size)$203.68 (1)
Day Low / High$199.20 - 205.57
Volume31.1 M

Halozyme Therapeutics Q2 Misses Street Expectations, Reaffirms Guidance; Stock 2% Lower After-Hours

4:56PM ET 8/10/2020 MT Newswires
Halozyme Therapeutics (HALO) on Monday reported a net profit of $0.19 per share in Q2, reversing from a net loss of $0.10 per share a year ago, as revenue grew to $55.22 million from $39.15 million over the same period.

Analysts polled by Capital IQ had expected a net profit of $0.24 per share on revenue of $66.68 million for the quarter.

For 2020, Halozyme continues to expect revenue of $230 million to $245 million and earnings of $0.60 to $0.75 per share, against the CIQ estimates of $0.76 for EPS on revenue of $235.21 million.

Price: 28.00, Change: -0.64, Percent Change: -2.23